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Background: There is strong but mostly circumstantial evidence that genetic factors modulate the severity of
influenza infection in humans. Using genetically diverse but fully inbred strains of mice it has been shown that
host sequence variants have a strong influence on the severity of influenza A disease progression. In particular,
C57BL/6J, the most widely used mouse strain in biomedical research, is comparatively resistant. In contrast,
DBA/2J is highly susceptible.
Results: To map regions of the genome responsible for differences in influenza susceptibility, we infected a
family of 53 BXD-type lines derived from a cross between C57BL/6J and DBA/2J strains with influenza A virus
(PR8, H1N1). We monitored body weight, survival, and mean time to death for 13 days after infection. Qivr5
(quantitative trait for influenza virus resistance on chromosome 5) was the largest and most significant QTL for
weight loss. The effect of Qivr5 was detectable on day 2 post infection, but was most pronounced on days 5 and 6.
Survival rate mapped to Qivr5, but additionally revealed a second significant locus on chromosome 19 (Qivr19).
Analysis of mean time to death affirmed both Qivr5 and Qivr19. In addition, we observed several regions of the
genome with suggestive linkage. There are potentially complex combinatorial interactions of the parental alleles
among loci. Analysis of multiple gene expression data sets and sequence variants in these strains highlights about
30 strong candidate genes across all loci that may control influenza A susceptibility and resistance.
Conclusions: We have mapped influenza susceptibility loci to chromosomes 2, 5, 16, 17, and 19. Body weight
and survival loci have a time-dependent profile that presumably reflects the temporal dynamic of the response to
infection. We highlight candidate genes in the respective intervals and review their possible biological function
during infection.Background
Influenza A virus represents a major health threat to
humans. The 1918 H1N1 pandemic caused at about 30
to 50 million deaths [1]. Seasonal influenza epidemics
cause high economic loss, morbidity and deaths every
year [2]. The course and outcome of an influenza A
virus infection is influenced by viral and host factors.
Host risk factors, like obesity or pregnancy, became evi-
dent during the recent swine flu pandemics [3,4].* Correspondence: kls@helmholtz-hzi.de
1Department of Infection Genetics, Helmholtz Centre for Infection Research
and University of Veterinary Medicine Hannover, 38124, Braunschweig,
Germany
Full list of author information is available at the end of the article
© 2012 Nedelko et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orFurthermore, genetic factors in humans associated with
a higher susceptibility to influenza infections and severe
disease outcome have been suspected for the 1918
pandemics, as well as the H5N1 human infections [5-7].
Recently, the importance of IFITM3 as a crucial factor
for host susceptibility has been demonstrated in mice
and humans [8].
The importance of host factors to host susceptibility
and resistance has been demonstrated clearly in animal
models. We and others have shown in mouse infection
models that the susceptibility of the host to influenza A
infection strongly depends on the genetic background
[9-17]. In particular, DBA/2J mice are highly susceptible
to many influenza A virus subtypes, including those thatl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adaptation to the mouse [9,13,16-18]. In contrast,
C57BL/6J mice are more resistant. After infection with
mouse-adapted H1N1 (PR8M virus), DBA/2J mice loss
weight very rapidly and die within 5–7 days post infec-
tion (p.i.), whereas C57BL/6J mice loss weight until days
6–8 after infection and regain their initial weight by
14 days p.i. [9,18]. Viral load in the lungs of DBA/2J
infected mice is much higher and lung pathology is very
severe compared to infected C57BL/6J mice. Also, the
production of chemokines and cytokines is much higher
in DBA/2J mice [9,18].
However, the genomic regions that are responsible for
the differential response after infection with H1N1 have
not been determined. Therefore, we used a large family
of BXD type recombinant inbred strains generated by
crossing C57BL/6J (resistant) to DBA/2J (susceptible) to
map genetic loci that modulate disease severity. The
BXD genetic reference population (GRP) is made up of a
set of progeny strains, each with a defined and fixed gen-
etic architecture. It is one of the largest families of
strains, consisting of about 80 fully inbred strains [19,20]
available from the Jackson Laboratory and a new set of
80 additional lines that are still in production at the Uni-
versity of Tennessee. Individuals within each single
strain are essentially isogenic (except for the sex chro-
mosomes) and genotypes for the entire family, including
most of the new strains, are known [21]. Genetic vari-
ation among this family has be exploited extensively in
the past to systematically study the genetics of many
traits (for examples of phenotypes see the GeneNetwork
database [22]).
Here, we infected over 50 of the BXD strains with
influenza A H1N1 virus and monitored body weight,
survival, and mean time to death for the following
13 days post infection. We identified two significant and
several suggestive loci peaks for all three traits. All
showed a time-dependent appearance. Data mining of
the intervals revealed several candidate genes, several
of which may be important for the host response to
influenza A virus infection.
Results
Susceptibility to influenza A virus after experimental
infection of BXD mouse strains is highly variable
We infected 53 recombinant inbred strains of the BXD
population plus the parental strains C57BL/6J, DBA/2J
and B6D2F1 mice with mouse-adapted H1N1 virus
(PR8M, H1N1 [18]) and followed body weight and
survival over the next 13 days. Mice that lost more than
25% of their starting weight were sacrificed and also
recorded as dead. After infection, body weight changes
were highly variable between the BXD strains over
the period of 13 days post infection (Figure 1, Additionalfile 1: Table S1). Similarly, survival rates (Additional
file 2: Figure S1A, B) and mean time to death (MTTD;
Additional file 2: Figure S1C) were highly variable
between the different BXD strains. Furthermore, the
trait percent survival showed a strain-dependent progres-
sion over time.
For body weight loss and survival, three different
phenotypic response groups can be defined (Figure 1). In
the first (Figure 1A), all infected mice within a strain sur-
vived, in the second (Figure 1B) a majority but not all
individuals within a strain survived, and in the third
group (Figure 1C), a majority died. Most remarkably, in
the first group four strains—BXD9, BXD13, BXD43,
BXD97—were highly resistant indicating that the infec-
tion may not cause any major pathology (Figure 1A). In
contrast, BXD28 belonging to the third group, lost body
weight much more rapidly than even the highly suscep-
tible DBA/2J parent (Figure 1C). These results illustrate a
large variation of responses within the BXD family.
By day 7 p.i., all infected mice had succumbed to
infection in 11 strains, whereas 14 others exhibited
more limited mortality (Additional file 2: Figure S1A). The
incidence of mortality increased in some strains from day
8 p.i. through day 11 but not thereafter (Additional file 2:
Figure S1B). For the MTTD phenotype, 17 strains showed
no mortality after infection, similar to the resistant
C57BL/6J parent. Three strains—BXD28, BXD18,
BXD103—exhibited a MTTD that was even shorter
than for the susceptible DBA/2J parent (Additional file 2:
Figure S1C). Although this study was conducted over a
period of approximately three years, and although mice
were received from different sources and different experi-
menters performed the infection experiments, we did not
note any significant influence of these potential confounds
and cofactors.
Principal Component Analysis (PCA) of strain mean
body weight loss from day 1 until day 7 was carried out
to reduce the number and redundancy of related mea-
surements, as well as to evaluate whether this set of mea-
surements can be broken down into statistically and
genetically independent processes. This analysis revealed
one major component, PC1 that explains most of the weight
loss among strains (more than 80%, see Additional file 3:
Figure S2). This component corresponds to differences
in loss from day 3 to 7 p.i. (Figure 2). In contrast, PC2
accounts for only about 10% of the variance in weight loss
(Additional file 3: Figure S2). This component corresponds
only to very early weight loss after virus inoculation, on
days 1 and 2 p.i.(Figure 2), well before any appreciable
virus replication has occurred. Thus, PC2 is highly likely to
be a technical, but still interesting effect associated with
the stressful procedure of intranasal inoculation and full
anesthesia. PC1 most likely reflects the biologically relevant
variation among strains in response to viral replication.
Figure 1 BXD strains exhibit variable kinetics of weight loss and survival after infection with Influenza A virus. Mice from 53 BXD and
parental strains were infected intra-nasally with 2 × 103 FFU of PR8 virus. Weight loss and survival of infected mice was followed over a period of
13 days. Mortality includes mice that were sacrificed because they had lost more than 25% of body weight. Three phenotypic groups can be
distinguished: in the first group (A), all infected mice within a given BXD strain survived, in the second group (B) less than 50% of infected mice
within a given BXD strain died, in the third group (C), more than 50% of infected mice within a given BXD strain died. From the weight loss
curve of the second and third group it also becomes obvious that non-surviving mice were all approaching the 75% body weight loss endpoint
before dying.
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on chromosome 5 and several suggestive QTLs with
time-dependent effects
We mapped body weight loss following infection day by
day. For purposes of analysis, body weights of mice that
had died or that were euthanized were assigned a weight
equal to 75% of their initial weight. It should be notedthat mice which died continuously lost weight and were
close to 75% body weight loss before they were found
dead (Figure 1B, C). After day 7, surviving mice started
to gain weight (Figure 1A, B). For this reason, we limited
our analyses of body weight traits to the period of day 1
to day 7 p.i. in order to avoid mixing data from dead
with recovering mice. Interval mapping of body weight
Figure 2 Principal component analysis of all body weight traits
reveals two distinct groups. PCA loading plot of principal
components PC1 and PC2 (Supplement Figure 2) for body weight
traits form day 1 to day 7 p.i. shows two distinct groups. The
variation of body weight loss at day 3 to day 7 (ID 13007 to ID
13011) are mainly represented by factor 1. On the other hand,
variation of body weight loss at day 1 (ID 13005) and 2 (ID 13006)
are most likely explained by factor 2.
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chromosome 5 that we named ‘QTL for influenza virus
resistance on chromosome 5’ (Qivr5) adopting the no-
menclature proposed by [12]. This QTL exhibited
genome-wide significance on days 5 (LRS: 19.0, effect
size: 30%) and 6 (LRS: 19.4, effect size: 31%, Figure 3).
However, the effect of Qivr5, although weaker, can also
be detected on days 2, 3, and 4 and 7 (Figure 3). Most
interestingly; the resistance allele at Qivr5 is inherited
from the nominally sensitive DBA/2J parental strain,
illustrating the genetic complexity of the influenza
response. Suggestive loci (LRS values between 10 and
15) map to chromosomes 2, 6, 9, proximal and distal 16,
and chromosome 17. The effect of these loci was also
time-dependent (Figure 3A-G).
Another suggestive QTL peak was found on chromo-
some 10 on day 1 (LRS: 14.1, effect size: 23%,
Figure 3A). Its effect is lower at day 2 and not apparent
at later days. These observations are in accordance with
the PCA (Figure 2) that reveals two separate time-
dependent influences on body weight variance among
strains. The QTL appeared at an early time point
after infection, when virus replication has just begun
and strong inflammatory host responses are not yet
evident [9,18,23]. These observations indicate that the
effect is most likely related to the experimental proto-
col, namely the stress to anesthesia and intra-nasal
application as well as treatment recovery. Treatment-
dependent QTLs were described previously [24]. It is
worth to note that mock-infection of the parental
DBA/2J and C57BL/6J mice did not lead to a lasting
body weight loss over a longer time interval except fora slight drop in body weight on day 1 p.i. (Additional
file 4: Figure S3).
We also performed a QTL analysis for the PC1 and
PC2 described above. PC1 detects a significant QTL on
chromosome 5 (LRS: 19, effect size: 30%, Figure 4A) as
well as suggestive QTL peaks on proximal chromosome
16 and on chromosome 17 (Figure 4A). Thus, the PC1
confirmed the significant QTL on chromosome 5 found
with the daily body weight loss traits. Interval mapping
of PC2 detected no significant QTL and one suggestive
QTL on chromosome 13 (Figure 4B) which was not seen
in any other trait.
Survival rate and mean time to death traits confirmed
the QTL on chromosome 5 and detected another
significant QTL on chromosome 19
The analysis of survival rate traits on days 7, 8 and 11 p.i.
revealed significant peaks on chromosomes 5 and 19 and
suggestive peaks on chromosomes 1, 2, 3, 10, 16 and 17
(Figure 5A-C). The effects of these QTLs were again
time-dependent. Qivr5 was significant at day 7 (LRS:
24.8, effect size: 37%) and day 8 p.i. (LRS: 19.7,
effect size: 31% Figure 5A, B) and its effect was still evi-
dent from day 9 until 11 p.i. (Additional file 5: Figure S4
and Figure 5C). Similarly, another significant QTL with
time-dependent effects was observed on chromosome 19
(Qivr19) at day 8 (LRS: 19.4; effect size: 29%) that could
also be detected at day 7 and days 9–11 (Figure 5A-C
and Additional file 5: Figure S4). Qivr5 and Qivr19
resulted from a positive influence of DBA/2J on survival,
whereas Qivr16 (distal locus) and Qivr17-2 resulted from
a positive influence of C57BL/6J alleles to increase sur-
vival. Furthermore, MTTD analysis confirmed Qivr5 as a
significant QTL (LRS: 20.5, effect size: 32%), and Qivr19
was almost significant for this trait (Figure 5D). In
addition, suggestive QTLs were found on chromosomes
2 and 17 for the MTTD trait.
In conclusion, survival and MTTD traits confirmed the
significant QTL on chromosome 5, revealed an additional
significant QTL on chromosome 19 and several suggest-
ive QTLs. All QTLs showed a time-dependent effect.
Composite interval and pair-scan mapping indicates
various interactions of QTLs
The strongest QTLs map to chromosomes 5 and 19. We
therefore performed composite interval mapping in
which the contributions of these strong QTLs were fac-
tored out to reveal possible secondary QTLs. When we
controlled for Qivr19, the linkage to distal chromosome
16 increased and became nearly significant for both sur-
vival at day 8 and MTTD (Figure 6A, B). The linkage to
chromosome 2 increased slightly. However, control for
the contribution of Qivr5 did not reveal any additional
loci linked to survival or MTTD traits (Figure 6C, D).
Figure 3 Genome-wide linkage analysis for body weight loss after H1N1 infection identifies time-dependent QTLs. Analysis of body
weight from day 1 (A), day 2 (B), day 3 (C), day 4 (D), day 5 (E), day 6 (F) and day 7 (G) after PR8 infection revealed time-dependent QTLs.
A significant QTL is located on chromosome 5 and suggestive QTLs are observed on chromosomes 2, 6, 9, 10, 16 and 17. Dead or euthanized
mice were included for the analysis by manually setting their body weight to 75%. Interval mapping is shown across the entire genome as blue
line representing the LRS scores; green line: DBA/2J alleles increase trait values; red line: C57BL/6J alleles increase trait values. Upper x-axis shows
mouse chromosomes, lower x-axis shows physical map in mega bases for each chromosome, y-axis represents LRS score. The horizontal lines
mark the genome-wide significant thresholds at p<0.05 (red line) and suggestive thresholds at p<0.37 (gray line).
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described above as well as possible epistatic interactions
among these QTLs. When using a full two-locus model
(Trait Variance =Q1+Q2+Q1 x Q2), we found two
potential interactions between Qivr5 and a new locus
on chromosome 9 as well as between Qivr5 and Qivr19,
respectively, for the survival trait at day 8 (Figure 7A).
The inclusion of an interaction term increases the LRS
by 23 (Additional file 6: Figure S5). For both Qivr5 -
chromosome 9 interaction (Figure 7B) and Qivr5 –
Qivr19 interaction (Figure 7C), the allele combination
DBA/2J / DBA/2J showed highest and the combination
C57BL/6J / C57BL/6J lowest survival scores. All differ-
ences were highly significant.Analysis of QTL regions identified several candidate
genes that may contribute to host susceptibility or
resistance
In total, the mapping studies revealed five QTLs on
chromosomes 2, 5, distal 16, 17 and 19 (Qivr2-2, Qivr5,
Qivr16, Qivr17-2 and Qivr19) that did merit further
analysis because they were consistently observed in at
least two traits and exerted an effect on at least two dif-
ferent days p.i.
For the candidate gene searches, we defined the critical
regions of the QTLs manually by considering peak
height, its shoulder and bootstraps as guidance (Figure 8).
We then investigated these Qivr intervals for potential
candidate genes that may be causal for the studied traits
Figure 4 Genome-wide linkage scan for PC1 and PC2 body weight loss. Interval mapping of principle component PC1 (A) for body weight
loss traits at day 1 to 7 after PR8 infection shows significant QTLs on chromosome 5 and suggestive QTLs on chromosomes 16 and 17. Interval
mapping of PC2 (B) for body weight loss traits reveals no significant QTLs and a suggestive QTL on chromosome 13. Interval mapping is shown
across the entire genome as blue line representing the LRS scores; green line: DBA/2J alleles increase trait values; red line: C57BL/6J alleles increase
trait values. Upper x-axis shows mouse chromosomes, lower x-axis shows physical map in mega bases for each chromosome, y-axis represents LRS
score. The horizontal lines mark the genome-wide significant thresholds at p<0.05 (red line) and suggestive thresholds at p<0.37 (gray line).
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tool in GeneNetwork [25] to identify all genes in the QTL
intervals and to obtain associated GO terms. Next, we
select all annotated genes within the QTL intervals that
were expressed between day 1 and day 60 after infection
of C57BL/6J mice with PR8M virus (the latter data set is
derived from a separate study (Pommerenke et al., PLoS
ONE, in press). Subsequently, these genes were further
characterized for the following attributes: genes that were
up- or up-regulated in infected lungs by at least 1.5-fold
in C57BL/6J after PR8M infection, genes carrying an in-
sertion or deletion or a non-synonymous nucleotide
change in the open reading frame, genes exhibiting a cis-
expression QTL in the lung [26], and genes that were dif-
ferentially expressed by at least 1.5-fold in C57BL/6J and
DBA/2J mice in infected lungs between day 1 and day 8p.i. [23] and Pommerenke et al., PLoS ONE, in press).
The strategy of the QTL mining is shown as flow chart in
the Additional file 7: Figure S6, and the final results are
presented in Table 1. Furthermore, the attributes of all
genes located in the QTL regions are listed in detail in
the Additional file 8: Table S2). Using these combined
attributes, we identified 31 genes as the most likely candi-
dates to regulate the traits controlled by Qivr2-2, Qivr5,
Qivr16, Qivr17-2 and Qivr19 (listed in Table 2). These
genes were further evaluated based on their known func-
tion from the literature and phenotypes in knock-out
mouse mutants (see discussion).
Discussion
DBA/2J and C57BL/6J mice have been shown pre-
viously to differ largely in their susceptibility to H1N1
Figure 5 Genome-wide linkage scan for survival rate and mean time to death confirms QTLs on chromosomes 5 and 19. Interval
mapping of survival rates (in %) after PR8 infection at day 7 (A), day 8 (B) and day 11 (C) show significant QTLs on chromosomes 5 and 19.
Suggestive QTLs are observed on chromosomes 2, 3, 10, 16 and 17. Interval mapping using mean time to death confirmed the significant QTL on
chromosome 5 and revealed suggestive QTLs on chromosomes 2, 17 and 19 (D). Interval mapping is shown across the entire genome as blue
line representing the LRS scores; green line: DBA/2J alleles increase trait values; red line: C57BL/6J alleles increase trait values. Upper x-axis shows
mouse chromosomes, lower x-axis shows physical map in mega bases for each chromosome, y-axis represents LRS score. The horizontal lines
mark the genome-wide significant thresholds at p<0.05 (red line) and suggestive thresholds at p<0.37 (gray line).
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Figure 6 Composite interval mapping indicates interactions of QTLs on chromosomes 5 and 19. The influence of the markers rs13483633
on chromosome 19 (A, B) and rs13478587 on chromosome 5 (C, D) was factored out and the residual LRS were calculated. Two different traits,
survival day 8 (A, C) and mean time of death (B, D) were tested by using the web tool of GeneNetwork. Interval mapping is shown across the
entire genome as blue line representing the LRS scores; green line: DBA/2J alleles increase trait values; red line: C57BL/6J alleles increase trait
values. Upper x-axis shows mouse chromosomes, lower x-axis shows physical map in mega bases for each chromosome, y-axis represents LRS
score. The horizontal lines mark the genome-wide significant thresholds at p<0.05 (red line) and suggestive thresholds at p<0.37 (gray line).
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Figure 7 Interactions are observed between several QTLs. The graph displays pair-scan results for the trait percent survival at day 8 p.i.
(ID13002) (A). The upper left half of the plot highlights any epistatic interactions, the lower right half provides a summary of LRS of the full
model, representing cumulative effects of linear and non-linear terms based on the model ‘Trait Variance=Q1+Q2+Q1 x Q2 ’. Subsequently,
BXD lines were grouped according to their allele combinations and trait values were compared between groups (B, C). The largest differences are
indicated by asterisks. They are highly significant between the respective groups (p < 0.0001). For the various loci, trait values for the following
markers were used: Qivr5: rs13478587, chromosome 9: rs6191976, Qivr19: rs13483633. Number of lines and p-values for Qivr5 – chromosome 9:
D2/D2: n = 17, D2/B6: n = 17, B6/D2: n = 6, B6/B6 n= 12; D2/D2 vs B6/B6: p < 0.0001, D2/B6 vs B6/B6: p = 0.003. Number of lines and p-values for
Qivr5 – Qivr19: D2/D2: n = 18, D2/B6: n = 16, B6/D2: n = 4, B6/B6: n = 14; p-values: D2/D2 vs B6/B6: p < 0.0001, D2/B6 vs B6/B6: p = 0.0008.
Abbreviations: D2: DBA/2J, B6: C57BL/6J.
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these studies and utilized the BXD recombinant inbred
set of mouse strains to map the genomic regions that
are responsible for differences in these two mouse
strains. We monitored three phenotypic traits, body
weight over time, survival over time and mean time to
death to identify quantitative trait for influenza resist-
ance. Two significant QTLs, Qivr5 and Qivr19, were
found on chromosomes 5 and 19, respectively. Fur-
thermore several suggestive QTLs, Qivr2-2, Qivr16 and
Qivr17-2 were observed in at least two traits and at
two days on chromosomes 2, 16 and 17, respectively.
Composite mapping revealed an additional almost sig-
nificant QTL at distal chromosome 16, Qivr16.
A similar analysis for host resistance to influenza has
been performed previously after infecting 66 BXD
strains with H5N1 influenza virus. This study reported
three significant QTLs on chromosomes 2, 7, and 17
[12]. Thus, none of these significant QTLs overlaps with
the QTLs identified in our analysis. Five of the strains
that were resistant (all infected mice survived) in ourstudy were also resistant in the study of [12] where a
total of 14 strains were found to be resistant. Five strains
that were highly susceptible in our study (100% of
infected mice died) were also highly susceptible in the
study by [12] of a total of 26 susceptible strains. Further-
more, five strains that were resistant in our study were
susceptible in the study by [12]. Thus, there is also
not much overlap between the two studies with respect
of susceptible and resistant strains. The differences
between the two studies are most likely explained by the
use of two different influenza virus subtypes. The H1N1
virus from our study represents a subtype with a mono-
basic hemagglutinin (HA) cleavage site, whereas the
H5N1 which was used in the study by Boon et al. is a
subtype with a polybasic HA cleavage site. The cellular
tropism of these two subtypes for virus replication and
processing is quite different, because monobasic viruses
are dependent on cell-specific proteases for the pro-
cessing of the HA whereas polybasic subtypes can be
processed by more ubiquitously expressed host pro-
teases, e.g. [27-32]. Therefore, the contribution of host
Figure 8 (See legend on next page.)
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(See figure on previous page.)
Figure 8 Detailed maps of QTLs contributing to host susceptibility and resistance to PR8 influenza A infection. Interval mapping was
performed for chromosomes 2 (A), 5 (B), 16 (C), 17 (D) and 19 (E). The critical intervals were selected based on the peak shapes and the
bootstrap signals: Qivr2-1 (56–68 Mb), Qivr5 (140–153 Mb), Qivr16 (64–78 Mb), Qivr17-2 (30–44 Mb) and Qivr19 (37–45 Mb). The Qivr intervals are
delineated by red arrows. The yellow bars represent the frequencies of peak LRS using bootstrap analysis. The multicolored chatters along the
top of the graph are hyperlinks to sites with additional genetic and sequence information. The orange chatter along the x-axis indicates the
density of SNPs present in the BXD strains. Interval mapping is shown across the entire genome as blue line representing the LRS scores; green
line: DBA/2J alleles increase trait values; red line: C57BL/6J alleles increase trait values. Upper x-axis shows mouse chromosomes, lower x-axis
shows physical map in mega bases for each chromosome, y-axis represents LRS score. The horizontal lines mark the genome-wide significant
thresholds at p<0.05 (red line) and suggestive thresholds at p<0.37 (gray line).
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and H5 containing virus subtypes.
Another study described the genetic mapping of sus-
ceptibility and resistance factors after infecting a panel
of 29 AxB / BxA congenic strains with a mouse-adapted
H3N2 influenza virus [33]. The AxB / BxA congenic
strains were generated from a cross of susceptible A/J
and resistant C57BL/6J parental mouse strains. The
authors found three major QTLs on chromosomes 2, 6
and 17. The QTL on chromosome 17 overlaps with the
Qivr17-2 locus which we found in our study. Further-
more, the candidate gene Pla2g7 that was identified in
their study was also detected as candidate gene in our
analysis (see below).
The influence of genetic factors determining the host
response to H1N1 influenza virus infections was also
examined in mice of the pre-Collaborative Cross collec-
tion [34]. In this study, gene expression levels in extreme
responders were used to identify expression QTLs
(eQTL). One gene that exhibited a cis-eQTL, Sik1 (salt
inducible kinase 1), was located in the Qivr17-2 interval
from our study, and we also identified it as potential
quantitative trait gene (Table 2). This gene is associated
with the GO terms ‘negative regulation of transcription
from RNA polymerase II promoter, regulation of cell
differentiation, and protein kinase cascade’. However, no
specific infection-related functions have been yet described
for this gene.
One of the most interesting findings in our study was
the time-dependent effect of QTLs which we observed
in the body weight and survival traits. The peak QTLs
for the two significant QTLs, Qivr5 and Qivr19, were
found at different times p.i., day 6 and day 8, respect-
ively. In addition, the effects of both QTLs were not only
evident at the times p.i. where they exerted the signifi-
cant peak QTL signals but also several days before and
after the peak. Furthermore, for the suggestive QTLs,
also time-dependent effects were observed. These results
suggest that the causal genes underlying different QTLs
act at different time points of the host defense.
Most interestingly, Qivr5 as well as Qivr19 represent a
positive influence on body weight, survival and MTTD
from the DBA/2J haplotype, the susceptible strain.These findings indicate that genomic regions from the
susceptible parent are able to increase resistance when
combined with the resistant parental genome. We are
now analyzing several BXD strains that were more
resistant than the parental C57BL/6J mice in more
detail. One possible mechanism to explain such an effect
may be that an activator (secreted ligand or transcription
factor) is expressed in susceptible DBA/2J mice but the
corresponding target (receptor or regulated gene) is
mutated. On the other hand, in C57BL/6J mice, the tar-
get but not the activator may be mutated. If the wild
type alleles are now coming together in a BXD strain,
the functional activator finds its functional target and
thereby an increased resistance state is achieved.
Both composite and interaction mapping revealed
many genetic interactions between C57BL/6J and
DBA/2 J alleles. Thus, many genomic regions from the
parental strains are able to contribute to the host re-
sponse and this effect depends strongly on the allele
combinations in the respective QTLs. These observa-
tions may be studied further in double congenic
mouse lines.
We subsequently analyzed the five QTL intervals,
Qivr2-2, Qivr5, Qivr16, Qivr17-2 and Qivr19 in more de-
tail to identify genes that may be causal for resistance or sus-
ceptibility. In total, 830 genes are located in these intervals. We
narrowed down the total number of genes to 31 candidates
(Table 2) by using additional information, such as temporal ex-
pression after PRM8 infection (Pommerenke et al., PLoS
ONE, in press), cis-eQTLs in non-infected lungs [26], dif-
ferences in expression between DBA/2J and C57BL/6J
[23], and sequence variants in the coding regions.
Qivr5 contains the candidate gene Eif2ak1 (eukaryotic
translation initiation factor 2 alpha kinase 1) that is a
member of eIF2alpha kinases which have been associated
with anti-viral host responses [35]. Boon et al. described
another eIF2alpha kinase, Eif2ak2 / Pkr (eukaryotic trans-
lation initiation factor 2-alpha kinase 2), in the Qirv17
locus after infection with influenza H5N1 [12]. Eif2ak2
plays a critical role in modulating immunoglobulin ex-
pression during RSV infection. In addition Eif2ak2 knock-
out mouse mutants are more susceptible to influenza
infections [36,37]. We have initiated the generation of a
Table 1 Candidate genes in mapped QTL intervals
Qivr Interval Allele
increasing
survival
No of
genes in
interval
No of genes
expressed
during infection
No of genes
with Indels
(FS in coding region)
No of genes with
SNPs (non-synonymous
codons / stop codons)
Cis-eQTLs in
non-infected lung
Differentially
expressed
btw B6/D2
(up-/down- regulated)
2-2 56-68 Mb D2 72 24 (19) - 4 / 0 6 3
5 140-153 Mb D2 179 83 (57) - 9 / 0 13 10
16 64-78 Mb B6 52 12 (7) 1a 5 / 0 4 4
17-2 30-44 Mb B6 370 158 (104) 1b 58 / 4c-f 32 40
19 37– 45 Mb D2 161 51 (30) 1g 14 / 1h 11 4
Up- or down-regulated genes were defined as genes that exhibited at least a 1.5 difference change in expression levels in lungs of infected mice compared to the
non-infected controls. Genes were defined as differentially expressed exhibiting at least a 1.5 difference in expression changes in infected lungs of C57BL/6J and
DBA/2J. Genes with sequence variations: aRobo1, bLst1, cBrd2, dH2-Ab1, eH2-Bl, fRpp21, gTctn3, hDhdpsI. Abbreviations: FS: frame shift in coding region, SNP: single
nucleotide polymorphism, cis-eQTL: cis regulated expression QTL, B6: C57BL/6J, D2: DBA/2J.
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verify and further characterize the effect of this region for
resistance to influenza infection.
Qivr2-2 contains two candidate genes, Itgb6 (integrin
beta 6) and Ifih1 (interferon induced with helicase C do-
main 1), with known functions in the host defense
to viral infections. Itgb6 mouse knock-out mutants
exhibit severe pneumonia and an increase in granulocyte
recruitment to the lung [38]. The protease-activated
receptor 1-mediated enhancement of Itgb6-dependent
TGF-beta activation has been proposed to represent one
mechanism by which activation of the coagulation cas-
cade contributes to the development of acute lung injury
[39]. The Ifih1 gene is also known as MDA5 (Melanoma
Differentiation-Associated protein 5). IFIH1 is part of
the RIG-I-like receptor (RLR) family, which function as
pattern recognition receptors and are activated upon
binding of virus dsRNA [40]. IFIH1 functions as cyto-
solic receptor that leads to the selective activation of type
I IFN genes and is indispensable for sustained expression
of IFN in response to paramyxovirus infection [41,42].
Ifih1 mutant knock-out mice exhibit an impaired response
to different viral pathogens [43,44].
Qivr16 contains two potential genes with known
functions in the host defense and lung function, Robo1
(roundabout homolog 1 (Drosophila)) and Nrip1 (nuclear
receptor interacting protein 1). DBA/2J mice carry a frame
shift mutation in the Robo1 gene which might lead to an
impaired function of the encoded protein. Robo1 has been
described to be involved in guidance and migration of axons,
myoblasts, and leukocytes in vertebrates (e.g. [45-47]) but is
also expressed in the developing lung [48]. Robo1 knock-
out mutants exhibit a delayed lung maturation and bron-
chial hyperplasia. The latter results suggest that Robo1
may be involved in maintaining proper lung function and
it may become essential when lung epithelium is
destroyed during an influenza infection. Nrip1/Rip140
functions as a co-activator for cytokine gene promoter ac-
tivity via direct protein-protein interactions with theNFkappaB subunit RelA and histone acetylase cAMP-
responsive element binding protein (CREB)-binding pro-
tein (CBP) [49]. It is involved in modulating pro-
inflammatory responses in macrophages [50].
Qivr17-2 represents a positive influence of the C57BL/6 J
genotype on body weight, survival and MTTD. This
QTL is located in a gene-rich region which carries many
genes that are involved in the host immune response,
in particular the H2 histocompatibility genes which are
involved in antigen presentation [51]. Therefore, many
candidate genes are found in the Qivr17-2 region. The
Lst1 (leukocyte specific transcript 1) gene is of special
interest because the DBA/2J allele mice carries a single
nucleotide deletion in the first exon resulting in a frame
shift of the open reading frame. This mutation most
likely results in a non-functional Lst1 protein in DBA/2 J
mice. We confirmed the presence of the deletion by se-
quencing the parental DBA/2J and some BXD strains car-
rying the DBA/2J allele. The wild type allele was
confirmed in C57BL/6J mice and in some BXD strains
carrying the C57BL/6J allele. In humans, LST1 plays a
role in the regulation of the immune response to in-
flammatory diseases such as rheumatoid arthritis, mi-
crobial infection or Rubella vaccine-induced immunity
[52-55]. Also, Lst1 is up-regulated after influenza A in-
fection in C57BL/6J mice starting at day 2 and exhibits
a strong peak of expression at day 8 p.i. Pommerenke
et al., 2012 (Pommerenke, C., E. Wilk, B. Srivastava, A.
Schulze, N. Novoselova, R. Geffers, and K. Schughart.
2012. Global transcriptome analysis in influenza-infected
mouse lungs reveals the kinetics of innate and adaptive
host immune responses. PLoS ONE. 7:e41169.). Thus,
the expression profile and known functions of Lst1 fit
well with a possible critical role for the host defense to
influenza A virus. We initiated the generation of knock-
out mice to evaluate the role of Lst1 in more detail. In
addition, a second, most interesting candidate, Pla2g7
(phospholipase A2, group VII (platelet-activating factor acetyl-
hydrolase, plasma)) was identified in the Qivr17-2 interval. In
Table 2 GO-terms and functions observed in knock-out mice of 31 potential candidates from QTL intervals
Qivr Gene
symbol
Gene description Function KO phenotype Type
polymorphism
in ORF
Qivr2-2 Itgb6 integrin beta 6 Integrin-mediated signaling
pathway, inflammatory response,
cell-matrix adhesion
Baldness associated with
macrophage infiltration of skin,
exaggerated pulmonary
inflammation, impaired mucosal
mast cell response to nematode
infection.
ns (1)
Qivr2-2 Ifih1 interferon induced with
helicase C domain 1
Response to virus, innate
immune response, regulation
of apoptosis, RIG-I-like receptor
signaling pathway
Increased virus-associated morbidity
and mortality, decreased cytokine
response to several viral infection.
ns (5)
Qivr5 Eif3b eukaryotic translation
initiation factor 3,
subunit B
Translation, translation initiation NA ns (1)
Qivr5 Sdk1 sidekick homolog 1
(chicken)
Cell adhesion NA ns (1)
Qivr5 Eif2ak1 eukaryotic translation
initiation factor 2 alpha
kinase 1
Negative regulation of translation,
response to stress, negative
regulation of cell proliferation,
regulation of eIF2 alpha
phosphorylation by heme
Enlarged heart size, abnormal
red blood cell development,
morphology, physiology with
macrocytic anemia.
ns (1)
Qivr5 Rnf6 ring finger protein
(C3H2C3 type) 6
Ubiquitin-dependent protein
catabolic process, positive
regulation of transcription,
DNA-dependent
NA ns (2)
Qivr16 Robo1 roundabout homolog 1
(Drosophila)
Cell differentiation, axon guidance,
chemotaxis
Neonatal death, aphagia, delayed
lung maturation and bronchial
hyperplasia.
insertion
Qivr16 Nrip1 Nuclear receptor
interaacting protein 1
Regulation of transcription Female infertility due to ovulation
failure. Male and female mice are
smaller than wild-type littermates.
ns (1)
Qivr16 Usp25 ubiquitin specific
peptidase 25
Ubiquitin-dependent protein
catabolic process
NA ns (1)
Qivr17-1 Cryaa crystallin, alpha A Negative regulation of apoptosis,
negative regulation of caspase
activity, lens fiber cell
morphogenesis
Small lenses that develop
progressive opacity beginning
in the nucleus.
no
Qivr17-2 Snf1lk/Sik1 SNF1-like kinase Negative regulation of transcription
from RNA polymerase II promoter,
regulation of cell differentiation,
protein kinase cascade
NA no
Qivr17-2 March2 membrane-associated
ring finger (C3HC4) 2
Endocytosis, biological process NA no
Qivr17-2 Tapbp TAP binding protein Antigen processing and
presentation of exogenous peptide
antigen via MHC class I,
TAP-dependent; defense response
Reduced and thermolabile MHC
class I surface expression due to
impaired peptide loading with
stabilizing peptides, impaired
T cell selection, altered NK
repertoire, lower CD8+ T cell
numbers, impaired responses to
select class I-restricted antigens.
ns (1)
Qivr17-2 H2-Oa histocompatibility 2,
O region alpha locus
Antigen processing and presentation
of peptide or polysaccharide antigen
via MHC class II, regulation of T cell
differentiation, Graft-versus-host
disease, viral myocarditis
Abnormal antigen presentation
via MHC class II, enhanced
selection of CD4+ single positive
thymocytes. Mice homozygous
for a different knock-out allele
show increased serum IgG1 levels.
ns (1)
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Table 2 GO-terms and functions observed in knock-out mice of 31 potential candidates from QTL intervals (Continued)
Qivr17-2 H2-DMa histocompatibility 2,
class II, locus DMa
Antigen processing and presentation
of exogenous peptide antigen via
MHC class II, positive regulation of
T cell differentiation, positive
regulation of immune response,
Graft-versus-host disease, viral
myocarditis
Impaired antigen presenting cell
function, poor IgG responses to
T-dependent antigens, reduced
numbers of mature CD4+ T cells,
increased susceptibility to
Leishmania major infection.
ns (2)
Qivr17-2 Tap2 transporter 2, ATP-binding
cassette, sub-family B
(MDR/TAP)
Antigen processing and presentation
of exogenous protein antigen via
MHC class Ib, TAP-dependent;
positive regulation of T cell mediated
cytotoxicity, protection from natural
killer cell mediated cytotoxicity
No CD8+ T cells, although
numbers of CD4+ T cells and
B cells are normal.
ns (6)
Qivr17-2 H2-Ob histocompatibility 2,
O region beta locus
Antigen processing and presentation
of peptide or polysaccharide antigen
via MHC class II, Graft-versus-host
disease, viral myocarditis
NA ns (7)
Qivr17-2 H2-Ab1 histocompatibility 2,
class II antigen A, beta 1
Antigen processing and presentation
of peptide or polysaccharide antigen
via MHC class II, Graft-versus-host
disease, viral myocarditis
Depletion of mature CD4+ T cells,
deficiency in cell-mediated
immune responses, increased
susceptibility to viral infections.
ns (9)
stop_L
Qivr17-2 H2-Aa histocompatibility 2,
class II antigen A, alpha
Antigen processing and presentation
of exogenous peptide antigen via
MHC class II, positive regulation of
T cell differentiation, Graft-versus-host
disease, viral myocarditis
Lack of cell surface expression
of MHC class II molecules on
macrophages, decreased
CD4-positive T cell number,
increased CD8-positive
T cell number, thymus hyperplasia,
enlarged lymph nodes, altered
splenocyte response to
staphylococcal enterotoxin B.
ns (10)
Qivr17-2 Lst1 leukocyte specific
transcript 1
Negative regulation of lymphocyte
proliferation, immune response,
cell morphogenesis
NA ns (1)
deletion
Qivr17-2 Gtf2h4 general transcription
factor II H, polypeptide 4
Regulation of transcription,
DNA-dependent
NA ns (3)
Qivr17-2 H2-T23 histocompatibility 2,
T region locus 23
Antigen processing and presentation
of peptide antigen via MHC class I,
Graft-versus-host disease, viral
myocarditis
CD4+ T cells have enhanced
responses after infection or
immunization, are resistant to
suppressor activity mediated by
a subset of CD8+ T cells, but are
more susceptible to NK cell lysis.
ns (3)
Qivr17-2 H2-Bl histocompatibility 2,
blastocyst
Antigen processing and presentation NA ns (4)
stop_L
Qivr17-2 Rpp21 ribonuclease P 21
subunit (human)
tRNA processing NA ns (1)
stop_G
Qivr17-2 Trim26 tripartite motif
protein 26
Biological process NA ns (1)
Qivr17-2 Pla2g7 phospholipase A2,
group VII (platelet-activating
factor acetylhydrolase,
plasma)
Inflammatory response, lipid catabolic
process
NA ns (1)
Qivr17-2 Cyp39a1 cytochrome P450,
family 39, subfamily a,
polypeptide 1
Lipid metabolic process, oxidation
reduction
NA ns (2)
Qivr-19 Sorbs1 sorbin and SH3 domain
containing 1
Transport, focal adhesion assembly,
positive regulation of establishment
of protein localization in plasma
membrane
Decreased triglyceride levels,
altered glucose homeostasis,
decreased white blood cells and
resistance to developing glucose
intolerance induced by a high
fat diet.
ns (6)
Qivr-19 Tctn3 tectonic family member 3 Apoptosis NA ns (1)
insertion (2)
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Table 2 GO-terms and functions observed in knock-out mice of 31 potential candidates from QTL intervals (Continued)
Qivr-19 Hps1 Hermansky-Pudlak
syndrome 1 homolog
(human)
Positive regulation of natural killer
cell activation, secretion of lysosomal
enzymes
Hypopigmentation and increased
bleeding time. Impaired natural
killer cell function, reduced
secretion of kidney lysosomal
enzymes, abnormal retinofugal
neuronal projections
characterize some alleles.
ns (6)
Qivr-19 Dnmbp dynamin binding protein Intracellular signaling cascade,
regulation of Rho protein signal
transduction
NA ns (3)
The genotype of C57BL/6J was used as reference for the sequence polymorphisms. The knockout mutant phenotype was identified in the MGI Mouse Genome
Database. Gene Fign (fidgetin) fulfilled most criteria but was found to be expressed only at late times p.i. (after day 14) and was therefore omitted from the
candidate gene list. Abbreviations: KO: knockout mutant, NA: not analyzed, SNP: single nucleotide polymorphism, ns: non-synonymous codons, ORF: open reading
frame, stop_G: stop codon gained, stop_L: stop codon lost.
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were associated with early coronary atherosclerosis and
with endothelial dysfunction, but the gene may also exert
an anti-inflammatory function [56-60]. The Pla2g7 gene
was also identified as a potential candidate gene for suscep-
tibility against infections with H3N2 influenza virus [33].
Pla2g7 expression levels in susceptible A/J mice were
higher than in resistant C57BL/6J mice after infection with
H3N2 virus [33]. We also showed previously that Pla2g7
exhibits a cis-eQTL between C57BL/6J and DBA/2J in
non-infected lungs where the DBA/2J allele shows high
levels of expression [26]. Tnfrsf21 which was identified by
[33] as potential candidate of Qivr17-2 also exhibits a cis-
eQTL in non-infected BXD mice [26] but was not found to
be regulated in C57BL/6 mice after infection (data not pub-
lished). Tapbp (TAP binding protein) plays a major role in
the antigen processing and MHC class I presentation by
stabilizing the TAP peptide transporter, e.g. [61-65]. Also,
Tap2 (transporter 2, ATP-binding cassette, sub-family B
(MDR/TAP)) gene is involved in antigen processing and
presentation [63,66]. Gtf2h4 (general transcription factor II
H, polypeptide 4) encodes a general transcription factor.
Recruitment and activation of Gtf2h4 represents a rate-
limiting step for the emergence of HIV from latency and se-
quence variants have been associated with multiple scler-
osis [67-69].
Within the Qivr19 interval, only one gene, Hps1
(Hermansky-Pudlak syndrome 1 homolog (human)),
has been associated with the host responses to infection.
Mice carrying a natural mutation in the Hps1 gene
showed an increased inflammatory response in alveolar
macrophages after intranasal challenge with LPS [70].
The GeneNetwork database allows searching for other
phenotypic traits that exhibit a genome-wide significant
(LRS≥ 18) within the Qivr intervals identified by our study.
Two phenotypic traits, related to neuronal responses (trait
ID 11285) and body weight changes (trait ID 12838), are
located to the Qivr16 locus. Also, the Qivr17-2 interval
contained significant QTLs for other traits. Two traits are
related to host infectious diseases, ‘Ectromelia virus survival’(ID 12672) and ‘Chlamydia psittaci (6BC) infection re-
sponse’ (ID 11025) and four traits are associated with im-
mune cell responses (ID 10201, 10466, 10238, 10236). In
addition two traits described seizure responses (ID 10388,
10507), and one trait has not been disclosed yet (ID 13920).
Within the early time chromosome 10 interval, three other
traits exhibit their most significant QTLs: ‘3a,5a-THDOC
in blood plasma 3 days after cycle 5 of chronic intermittent
air vapor’ (ID13027) and two non-disclosed traits. The first
trait may relate to stress responses in the central nervous
system (ID 13292 and 13846).
Conclusions
The mapping of resistance and susceptibility loci in the
BXD population revealed several new QTLs and poten-
tial gene candidates that may be critical for the host
defense against influenza A virus infection. Body weight
and survival QTLs showed a time-dependent profile in-
dicating that the genetic factors in these QTLs are im-
portant for the host response in a temporal dynamic
fashion. Five QTL regions were examined in detail, and
we identified several possible candidate genes that may
be critical for the host response to influenza A infections
in humans.
Methods
Animals
The mouse inbred strains C57BL/6J, DBA/2J and
B6D2F1 were delivered from Janvier, France. Recombin-
ant inbred mouse strains BXD were purchased from three
different sources: The Jackson Laboratory, the University
of Tennessee Health Science Center (Memphis, TN) and
from Harlan, The Netherlands. For the analysis, mice
were transferred to the animal facility in Braun-
schweig and adapted for at least two weeks to the
new environment before starting experiments. Ani-
mals were maintained under specific pathogen free
conditions. All experiments in mice were approved by
an external committee and according to the national
guidelines of the animal welfare law in Germany
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chung vom 18. Mai 2006 (BGBl. I S. 1206, 1313), das
zuletzt durch Artikel 20 des Gesetzes vom 9. Dezem-
ber 2010 (BGBl. I S. 1934) geändert worden ist.’). The
protocol used in these experiments has been reviewed
by an ethics committee and approved by the ‘Nieder-
sächsisches Landesamt für Verbraucherschutz und
Lebensmittelsicherheit, Oldenburg, Germany’, accord-
ing to the German animal welfare law (Permit Num-
bers: 33.42502/04-108/06, 33.9.42502-04-051/09).
Virus and infection of mice
The mouse-adapted influenza strain A/Puerto Rico/8/34
(H1N1; PR8M, [18] and references therein) was used
for all infection studies. Stocks were prepared by infec-
tion of 10-day-old embryonated chicken eggs. After
mice were anesthetized by intra-peritoneal injection of
Ketamin-Xylazine solution in sterile NaCl (50 mg/ml
Ketamine, Invesa Arzneimittel GmbH, Freiburg; 2%
Xylazine, Bayer Health-Care, Leverkusen) with a dose
adjusted to the individual body weight, mice were
infected intranasally with 2 × 103 FFU of PR8M in 20 μl
of sterile phosphate-buffered saline. Mice were assayed
daily for body weight (determined as % of initial weight
at day 0) and mortality during 13 days p.i. We used
death as the end point for survival. Mice were sacrificed
if body weight loss exceeded 25%. It should be noted
that for mice that did not show any signs of body weight
loss over the entire time period after infection, we do
not have additional parameters to verify that they have
indeed been infected. However, these cases were very
few. In addition, we have ample experience with this
infection method and the failure rate, for example with
the DBA/2J strain, is less that 5%.
Data handling and statistical analysis
In total, 283 BXD mice and 127 mice from the parental
strains or F1 generation were used for the infection experi-
ments. In total 53 BXD strains were infected with an aver-
age of 5 mice per strain. We performed all primary
calculations using simple features and functions of Micro-
soft Excel. Three sets of analysis were performed for the fol-
lowing variables: (1) body weight in percentage from
starting weight (day 0) using the strain medians to exclude
outliers; (2) survival by calculating the survival rate of each
strain from day 7 to 13, (3) mean time to death in days. For
statistical analyses, tests and visualization we used R, a free
software environment for statistical computing and graph-
ics (http://www.R-project.org). In order to test for batch
effects or other co-factors, we visualized the data using
multidimensional scaling based on the Sammon mapping
method [71]. No clusters with respect to any of the co-
factors age, weight at day 0, experimenter, time of infection,
or source of mice could be found in the visualizations.QTL mapping
QTL mapping was performed using the web-based com-
plex trait analysis available on the GeneNetwork website
(www.genenetwork.org) and the mapping module to
analyze phenotypes in context of mouse genotypic differ-
ences. Interval mapping evaluates potential QTLs at
regular intervals and estimates the significance at each
location with a graphical representation of the likelihood
ratio statistics (LRS) using 2000 permutation tests
[19,22]. LRS values may be converted to LOD scores by
dividing by 4.61. For the two locus model the following
equation was used: Var =Q1+Q2+Q1xQ2 + e, where
Var= the between-strain mean variance in the trait, Q1
and Q2 are makers tightly linked to the loci, Q1XQ2
is the ‘additive-by-additive’ epistatic interaction term,
and e is the residual error. The original data sets can be
obtained at www.genenetwork.org with the following
identification numbers: body weight: 13005 to 13017;
survival: 13000 to 13004 and mean time to death: 12996.
We performed full genome scans for epistatic interac-
tions using the pair-scan module that is implemented in
GeneNetwork. This module exploits the direct global
optimization algorithm developed by [72]. The code
compares the fit (as measured by LRS scores) for a
purely additive model, a purely epistatic model, and the
full model. The code also implements a permutation test
(n = 500) and this enabled us to estimate the empirical p
value of the alternative models.
Candidate gene discovery
The QTL region analysis was initially performed
using the QTLminer which has been implemented in
GeneNetwork [25]. By using the automatic function
of GeneNetwork we identified significant cis-QTLs
with LRS higher than 18 at a genome-wide p-value
of < 0.05. Additionally the genes mapped within the
analyzed QTLs were surveyed by the National Center
for Biotechnology Information (NCBI) Entrez Gene
website (http://www.ncbi.nlm.nih.gov/sites/entrez?db=
gene) and the Jackson Laboratory's MGI Mouse
Genome Database project (http://www.informatics.
jax.org/) to identify potential candidate genes. The
GeneRIF database (http://www.ncbi.nlm.nih.gov/pro-
jects/GeneRIF/GeneRIFhelp.html) was used as a pri-
mary source to search for known gene functions and
corresponding citations.
All sequence variants between B6 and D2 parental
genomes (SNPs, indels) were extracted by using a
comparative analysis that relies on approximately 100x
whole genome shot gun of DBA/2J [73]. All of these
sequence data are available at http://ucscbrowser.
genenetwork.org/, the GeneNetwork Variant Browser
(http://www.genenetwork.org/webqtl/main.py?FormID=
snpBrowser), and the NCBI Short Read Archive (18 files
Nedelko et al. BMC Genomics 2012, 13:411 Page 17 of 19
http://www.biomedcentral.com/1471-2164/13/411total, e.g., SRX037575, SRX013980, SRX013299, SRX012582,
SRX012581, SRX012580); http://www.biomedcentral.com/
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Additional file 1: Table S1. Body weight loss from day 1 until day 7 for
all strains showing the mean values, SEM per day and number of mice
per strain analyzed.
Additional file 2: Figure S1. Differential susceptibility to influenza A
infection among different BXD strains, parental strains and F1 generation.
Rank-ordered strain distribution pattern illustrating the percentage of
surviving mice per strain after influenza A infection for 53 BXD, parental
DBA/2J and C57BL/6J strains and F1 (B6D2F1) mice for day 7 (A, trait ID:
13001) and day 8 (B, trait ID: 13002). Rank-ordered strain distribution
pattern showing mean time to death for 53 BXD, parental DBA/2J and
C57BL/6J strains and F1 (B6D2F1) mice (C, trait ID: 12996).
Additional file 3: Figure S2. Principal component analysis of all body
weight traits. Percent contribution of principal components to the total
variance for body weight traits from day 1 until day 7 p.i. PC1 contributes
about 80% and PC2 about 10% to the total variance.
Additional file 4: Figure S3. Body weight changes in mock-infected
C57BL/6J and DBA/2J mice. Female DBA/2J (n=4) and C57BL/6J (n=3)
mice were intranasally inoculated with 25 μl PBS under anesthesia. Body
weight changes for each group of treated mice at various days p.i. is
shown with reference to the starting weight (% body weight). Data
represent mean values +/- SEM.
Additional file 5: Figure S4. Genome-wide linkage analysis for survival
after H1N1 infection at days 9 and 10 p.i. Analysis of survival from day 9
(A) and day 10 (B) after PR8 infection revealed suggestive QTLs on
chromosomes 5, 16, 17 and 19. Interval mapping is shown across the
entire genome as blue line representing the LRS scores; green line: DBA/
2J alleles increase trait values; red line: C57BL/6J alleles increase trait
values. Upper x-axis shows mouse chromosomes, lower x-axis shows
physical map in mega bases for each chromosome, y-axis represents LRS
score. The horizontal lines mark the genome-wide significant thresholds
at p0.05 (red line) and suggestive thresholds at p0.37 (gray line).
Additional file 6: Figure S5. Pair Scan analysis of trait 13002. The table
provides the breakdown of trait 13002 as an example for a pair scan
analysis study that compares the fit of the alternative models. An analysis
of this type can be regenerated rapidly on any of the traits presented in
our manuscript.
Additional file 7: Figure S6. Scheme to identify potential candidate
genes in the analyzed QTL intervals. The detailed steps are described in
the main manuscript.
Additional file 8: Table S2. List of genes in the QTL intervals that were
studied in detail. The QTLminer tool in GeneNetwork was to identify all
genes in the QTL intervals and to obtain associated GO terms and KEGG
pathways. All annotated genes within the QTL intervals that were
expressed between day 1 and day 60 after infection of C57BL/6J mice
with PR8M virus were further analyzed for the following attributes: genes
that were up- or down-regulated in infected lungs after PR8M infection,
genes carrying an insertion or deletion or a non-synonymous nucleotide
change in the open reading frame, genes exhibiting a cis-expression QTL
in the lung, and genes that were differentially expressed in C57BL/6J and
DBA/2J mice in infected lungs between day 1 and day 8 p.i.
Abbreviations: FS: frame shift in coding region, SNP: single nucleotide
polymorphism, cis-eQTL: cis-regulated expression QTL, B6: C57BL/6J, D2:
DBA/2J, ns: non-synonymous codons, stop_G: stop codon gained, stop_L:
stop codon lost, DEL: deletion, INS: insertion; ns (. . .): number of non-
synonymous codons. Legends: Expression d0-d60, log2 ≥8 at any day
during infection; No: log2 8; ?: no expression data available. Regulation
during infection (d0-d60): + - up or down regulation, genes that
exhibited at least a 2-fold difference in changes of the expression levels
in lungs of infected mice compared to non-infected controls; (+)(-): up-or
down-regulation, genes that exhibited at least a1.5-fold difference in changes of the expression levels in lungs of infected
mice compared to the non-infected controls; no: no regulation. SNP: ns
(..) number of non-synonymous codons; STOP_L: Stop codon lost,
STOP_G: Stop codon gained; no: no SNPs between B6 and D2. Indel: DEL:
Deletion; INS: Insertion; no: no INDEL. cisQTL: yes (. . .): LRS value has to
be greater than ≥18; no: no QTL or LRS 18. diff expressed (B6-D2) during
infection: Genes were defined as differentially expressed (log2 ≥8) at any
day in infected lungs of C57BL/6J and DBA/2J; + -: Genes were defined
as differentially expressed exhibiting at least a 2.0 difference in changes
of the expression levels in infected lungs of C57BL/6J and DBA/2J; (+)(-)
differentially expressed: Genes were defined as differentially expressed
exhibiting at least a 1.5 difference in changes of the expression levels in
infected lungs of C57BL/6J and DBA/2J; no: no regulation or not
expressed; Score: the different attributes were counted.
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